Comparison of Treatment and Outcome of Acute Coronary Syndrome in Patients With Versus Patients Without Diabetes Mellitus

American Journal of Cardiology

Volumn 103, Issue 6, 2009, Pages 772-778

  Hasin, Tal ^a   Hochadel, Matthias ^d   Gitt, Anselm K ^d   Behar, Shlomo ^c   Bueno, Héctor ^e   Hasin, Yonathan ^b  

^a RAMBAM MEDICAL CENTER   (Israel)

^b Poria Medical Centre   (Israel)

^c SHEBA MEDICAL CENTER   (Israel)

^d UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^e HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INOTROPIC AGENT; INSULIN; NITRATE; ORAL ANTIDIABETIC AGENT; TICLOPIDINE;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; BLEEDING; COMORBIDITY; DIABETES MELLITUS; FEMALE; HEALTH CARE UTILIZATION; HEART ARRHYTHMIA; HEART FAILURE; HEART INFARCTION; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; ST SEGMENT ELEVATION;

ACUTE CORONARY SYNDROME; AGED; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; TREATMENT OUTCOME;

EID: 61349183164     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.11.034     Document Type: Article

References (18)

1. Mandelzweig L., Battler A., Boyko V., Bueno H., Danchin N., Filippatos G., Gitt A., Hasdai D., Hasin Y., Marrugat J., Van de Werf F., Wallentin L., et al. The second Euro Heart Survey on Acute Coronary Syndromes: characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004. Eur Heart J 27 (2006) 2285-2293
2. Bakhai A., Collinson J., Flather M.D., de Arenaza D.P., Shibata M.C., Wang D., and Adgey J.A. Diabetic patients with acute coronary syndromes in the UK: high risk and under treated. Results from the prospective registry of acute ischaemic syndromes in the UK (PRAIS-UK). Int J Cardiol 100 (2005) 79-84
3. Malmberg K., Yusuf S., Gerstein H.C., Brown J., Zhao F., Hunt D., Piegas L., Calvin J., Keltai M., and Budaj A. Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry. Circulation 102 (2000) 1014-1019
4. Hasdai D., Behar S., Boyko V., and Battler A. Treatment modalities of diabetes mellitus and outcomes of acute coronary syndromes. Coron Artery Dis 15 (2004) 129-135
5. Ryden L., Standl E., Bartnik M., Van den Berghe G., Betteridge J., de Boer M.J., Cosentino F., Jonsson B., Laakso M., Malmberg K., Priori S., Ostergren J., et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 28 (2007) 88-136
6. Roffi M., Chew D.P., Mukherjee D., Bhatt D.L., White J.A., Heeschen C., Hamm C.W., Moliterno D.J., Califf R.M., White H.D., Kleiman N.S., Theroux P., et al. Platelet glycoprotein IIb/IIIa inhibitors reduce mortality in diabetic patients with non-ST-segment-elevation acute coronary syndromes. Circulation 104 (2001) 2767-2771
7. Brooks M.M., Alderman E.L., Bates E., Bourassa M., Califf R.M., Chaitman B.R., Detre K.M., Feit F., Frye R.L., Gibbons R.J., Hardison R.M., Hlatky M.A., et al. The final 10-year follow-up results from the BARI randomized trial. J Am Coll Cardiol 49 (2007) 1600-1606
8. Malmberg K., Ryden L., Hamsten A., Herlitz J., Waldenstrom A., and Wedel H. Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. Diabetes Insulin-Glucose in Acute Myocardial Infarction. DIGAMI Study Group. Eur Heart J 17 (1996) 1337-1344
9. Malmberg K. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. BMJ 314 (1997) 1512-1515
10. McGuire D.K., Emanuelsson H., Granger C.B., Magnus O.E., Moliterno D.J., White H.D., Ardissino D., Box J.W., Califf R.M., and Topol E.J. Influence of diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes. Findings from the GUSTO-IIb Study. GUSTO IIb Investigators. Eur Heart J 21 (2000) 1750-1758
11. Franklin K., Goldberg R.J., Spencer F., Klein W., Budaj A., Brieger D., Marre M., Steg P.G., Gowda N., and Gore J.M. Implications of diabetes in patients with acute coronary syndromes. The Global Registry of Acute Coronary Events. Arch Intern Med 164 (2004) 1457-1463
12. Norhammar A., Malmberg K., Ryden L., Tornvall P., Stenestrand U., and Wallentin L. Under utilisation of evidence-based treatment partially explains for the unfavourable prognosis in diabetic patients with acute myocardial infarction. Eur Heart J 24 (2003) 838-844
13. Anselmino M., Bartnik M., Malmberg K., and Ryden L. Management of coronary artery disease in patients with and without diabetes mellitus. Acute management reasonable but secondary prevention unacceptably poor: a report from the Euro Heart Survey on Diabetes and the Heart. Eur J Cardiovasc Prev Rehabil 14 (2007) 28-36
14. Lenzen M., Ryden L., Ohrvik J., Bartnik M., Malmberg K., Scholte Op Reimer W., and Simoons M.L. Diabetes known or newly detected, but not impaired glucose regulation, has a negative influence on 1-year outcome in patients with coronary artery disease: a report from the Euro Heart Survey on Diabetes and the Heart. Eur Heart J 27 (2006) 2969-2974
15. Abbud Z.A., Shindler D.M., Wilson A.C., and Kostis J.B. Effect of diabetes mellitus on short- and long-term mortality rates of patients with acute myocardial infarction: a statewide study. Myocardial Infarction Data Acquisition System Study Group. Am Heart J 130 (1995) 51-58
16. Melchior T., Kober L., Madsen C.R., Seibaek M., Jensen G.V., Hildebrandt P., and Torp-Pedersen C. Accelerating impact of diabetes mellitus on mortality in the years following an acute myocardial infarction. Trandolapril Cardiac Evaluation. TRACE Study Group. Eur Heart J 20 (1999) 973-978
17. Dotevall A., Hasdai D., Wallentin L., Battler A., and Rosengren A. Diabetes mellitus: clinical presentation and outcome in men and women with acute coronary syndromes. Data from the Euro Heart Survey ACS. Diabet Med 22 (2005) 1542-1550
18. Cannon C.P., Weintraub W.S., Demopoulos L.A., Vicari R., Frey M.J., Lakkis N., Neumann F.J., Robertson D.H., DeLucca P.T., DiBattiste P.M., Gibson C.M., and Braunwald E. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 344 (2001) 1879-1887